Teradyne (TER) Cost of Revenue (2009 - 2026)

Teradyne (TER) has 18 years of Cost of Revenue data on file, last reported at $501.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 85.52% year-over-year to $501.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 32.45% YoY), and the FY2025 full-year result was $1.3 billion, up 13.81% from the prior year.
• Cost of Revenue for Q1 2026 stood at $501.5 million, up from $463.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $501.5 million in Q1 2026 and bottomed at $260.5 million in Q1 2024.
• The 5-year median for Cost of Revenue is $304.0 million (2024), against an average of $319.6 million.
• The widest annual swing landed in 2022, when Cost of Revenue slipped 23.79%; it then jumped 85.52% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $311.4 million in 2022, then retreated by 6.53% to $291.1 million in 2023, then climbed by 5.0% to $305.6 million in 2024, then surged by 51.72% to $463.6 million in 2025, then rose by 8.17% to $501.5 million in 2026.
• The last three Cost of Revenue figures came in at $501.5 million (Q1 2026), $463.6 million (Q4 2025), and $319.9 million (Q3 2025), per Business Quant data.